Skip to main content

Alpine Immune Sciences, Inc.

ALPNDelisted May 20, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001626199

Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Alpine Immune Sciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of ALPN: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders5356+3
Shares18.6M24.7M+6.16M (+33.2%)
Value$257.1M$221.8M−$35.3M (−13.7%)

New holders (10)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to ALPN in Q1 2022
InstitutionSharesValue% of portfolio
Decheng Capital Management III (Cayman), LLC4,708,288$42.2M12.94%
Frazier Life Sciences Management, L.P.4,185,757$37.5M3.20%
Paradigm Biocapital Advisors LP336,229$3.02M0.80%
Jacobs Levy Equity Management, Inc138,279$1.24M0.01%
Kingsbury Capital Investment Advisors LLC29,153$262.0K0.29%
Susquehanna International Group, LLP12,421$111.0K0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)2,257$20.0K0.00%
Amalgamated Bank1,891$17.0K0.00%
Amalgamated Financial Corp.1,891$17.0K0.00%
FMR LLC266$2.00K0.00%

Sold out (7)

Institutions that held Alpine Immune Sciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of ALPN in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Frazier Management LLC1,784,913$24.7M
Logos Global Management LP1,120,000$15.5M
Acuta Capital Partners, LLC230,000$3.19M
Westwood Holdings Group Inc.23,079$319.0K
Jump Financial, LLC12,600$175.0K
Western Wealth Management, LLC12,360$171.0K
Parametric Portfolio Associates LLC10,875$151.0K